Rare
lephants
Screener
Toggle theme
Harrow, Inc.
HROW
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2023
FY2022
FY2021
FY2019
FY2018
Total Cash from Operations:
$43.9M
Line Item
Value
% of Total
Capital Expenditures
$887.0K
2.0%
Business Acquisitions
$4.4M
9.9%
Other Investing
$215.0K
0.5%
Other Financing
$0
0.0%
Other
$12.7M
29.0%
Net Cash Flow
$25.7M
58.5%
